VRAX Ratios | P/E, ROE & Valuation

On the Key Ratios page for VRAX (VRAX), the latest P/E shown frames valuation, while ROE indicates profitability and capital efficiency. Together with the current ratio shown and debt-to-equity shown, these signals help you judge whether valuation is supported by fundamentals across the historical rows.

Financial Performance Ratios

VRAX Historical Per Share Metrics

···
Metric (FY)
Revenue per Share
Net Income per Share
Operating Cash Flow per Share
Free Cash Flow per Share
Cash per Share
Book Value per Share
Tangible Book Value per Share
Interest Debt per Share
CAPEX per Share

VRAX Historical Valuation Ratios

···
Metric (FY)
Price to Earnings (P/E)
Price to Book (P/B)
Price to Sales (P/S)
Enterprise Value to EBITDA
EV to Sales
EV to Operating Cash Flow
EV to Free Cash Flow
Enterprise Value

VRAX Historical Profitability Ratios

···
Metric (FY)
Return on Equity (ROE)
Return on Invested Capital (ROIC)
Return on Tangible Assets
Earnings Yield
Free Cash Flow Yield
Dividend Yield

VRAX Historical Liquidity & Financial Strength

···
Metric (FY)
Current Ratio
Interest Coverage
Income Quality
Debt to Equity
Debt to Assets
Net Debt to EBITDA

VRAX Historical Efficiency Ratios

···
Metric (FY)
Receivables Turnover
Payables Turnover
Inventory Turnover
Days Sales Outstanding
Days Payables Outstanding
Days of Inventory on Hand

VRAX Historical Market Metrics

···
Metric (FY)
Enterprise Value to EBITDA
Market Cap
Enterprise Value
Dividend Yield
Payout Ratio

Related peers

Compare More →
NCEL
Kadimastem Ltd
$2.49
-0.40%
NKGN
NKGen Biotech, Inc. Common Stock
$0.07
+16.67%
R
Ryder System, Inc.
$221.38
+4.40%
GTBP
GT Biopharma, Inc.
$0.40
+2.81%
ARTL
Artelo Biosciences, Inc.
$4.86
-8.47%
V
Visa Inc.
$315.10
-0.26%

Frequently Asked Questions

Is VRAX stock overvalued based on its P/E ratio?

On this page, you can use the latest P/E (from the Key Ratios table) as your starting point and compare it to the company's multi-year P/E range in the historical rows. When the current P/E sits near its historical average, valuation may be broadly "in line." Investors typically then focus on trend direction (whether profitability and cash-flow metrics are improving) and balance-sheet risk (liquidity and leverage) rather than treating the P/E in isolation.

What is VRAX market cap?

Market cap is the market value of a company's equity and is commonly calculated as share price multiplied by shares outstanding. The Key Ratios table includes Market Cap so you can see the latest valuation size. Pair market cap with valuation multiples (P/E, P/B, P/S) so you can evaluate whether size also corresponds with "quality" and profitability. For a wider view across stocks, you can also use the stock screener.

What is a good P/E ratio for VRAX compared to its industry?

There isn't one universal "good" P/E - P/E should be judged against the business model and expected growth for its sector. A practical approach is: (1) compare the P/E on this page to VRAX's own historical range (shown across the table's rows), and (2) benchmark against peer companies using the Screener's P/E filters and the Peers Comparison/Compare tools. If profitability (ROE/ROIC) and cash-flow strength are improving, a higher P/E can be more defensible; if returns are slipping, even a lower P/E may be a value trap.

How does VRAX compare to its competitors in key financial ratios?

The fastest way to compare VRAX with competitors is to use the built-in "Peers Comparison" section on this page and the Compare tool. Focus on a small set of ratios that work together: P/E for valuation, ROE/ROIC for profitability and capital efficiency, current ratio and interest coverage for liquidity and solvency, and debt-to-equity for leverage risk. When you see VRAX outperform peers on profitability while keeping valuation and leverage reasonable, it often signals stronger fundamentals.

Is VRAX financially strong based on its ratios?

To assess whether VRAX is financially strong, review both profitability and balance-sheet risk together. Use the liquidity and leverage rows in the Key Ratios table (current ratio, interest coverage, and debt-to-equity) as your checklist for financial resilience. Then confirm the same story is supported by ROE/ROIC (quality of earnings) and by cash-flow backed metrics in the table.

What do VRAX's financial ratios say about its future growth?

Ratios are a way to see what the business is likely to sustain. Look for upward trends in profitability metrics (ROE and ROIC), improving earnings/cash-flow backed measures, and stable or strengthening liquidity. If VRAX is sustaining strong returns (for example ROE and ROIC) while debt levels and interest coverage remain manageable, growth expectations may be more credible. If valuation multiples expand while returns weaken, the market may be pricing optimistic growth ahead of results.